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ABSTRACT 
The anterolateral tract (ALT), which originates from neurons in lamina I and the deep dorsal 
horn, represents a major ascending output through which nociceptive information is transmitted to 
brain areas involved in pain perception. Although there is detailed quantitative information 
concerning the ALT in the rat, much less is known about this system in the mouse, which is 
increasingly being used for studies of spinal pain mechanisms because of the availability of 
genetically modified lines. The aim of this study was therefore to determine the extent to which 
information about the ALT in the rat can be extrapolated to the mouse. Our results suggest that as in 
the rat, most lamina I ALT projection neurons in the lumbar enlargement can be retrogradely 
labelled from the lateral parabrachial area, that the great majority of these cells (~90%) express the 
neurokinin 1 receptor (NK1r), and that these are larger than other NK1r-expressing neurons in this 
lamina. This means that many lamina I spinoparabrachial cells can be identified in NK1r-
immunostained sections from animals that have not received retrograde tracer injections. However, 
we also observed certain species differences, in particular we found that many spinoparabrachial 
cells in lamina III-IV lack the NK1r, meaning that they cannot be identified based solely on 
expression of this receptor. We also provide evidence that the vast majority of spinoparabrachial 
cells are glutamatergic, and that some express substance P. These findings will be important for 
studies designed to unravel the complex neuronal circuitry that underlies spinal pain processing. 
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Introduction 
Nociceptive, thermal and pruritic information is conveyed from spinal cord to brain through the 
anterolateral tract (ALT) [50]. Cells of origin of the ALT are concentrated in lamina I and scattered 
throughout the deeper laminae (III-VI). Their supraspinal targets include thalamus, periaqueductal 
grey matter (PAG), lateral parabrachial area (LPb) and certain medullary nuclei. Individual ALT 
neurons can send axon collaterals to several of these regions [2,22,30,41,47].   
Quantitative studies in rat lumbar enlargement have demonstrated that ALT projection cells 
account for ~5% of lamina I neurons. Virtually all of these can be retrogradely labelled from LPb, 
and they can therefore be classified as spinoparabrachial neurons [2,41,47]. Studies in rat suggest 
that the vast majority of lamina I spinoparabrachial neurons respond to noxious stimuli [5,7]. The 
neurokinin 1 receptor (NK1r), which is present at high levels in lamina I [8,10,25,55], is expressed 
by ~70-80% of lamina I ALT neurons in rat [4,15,50], and by a population of lamina III-IV 
projection neurons with dorsal dendrites that arborise in the superficial laminae [32,52]. NK1r-
expressing projection neurons in laminae I and III-IV are densely innervated by nociceptive primary 
afferents that contain substance P (SP) [24,32,53]. Ablation of NK1r+ neurons by intrathecal 
injection of SP-saporin conjugate results in dramatic reduction of hyperalgesia in chronic pain states 
[28,34], which is thought to result from destruction of NK1r-expressing ALT neurons [50]. 
Although the NK1r is also expressed by excitatory interneurons in lamina I [25], these are 
significantly smaller than the projection cells [3,11]. This means that NK1r-expressing projection 
neurons in rat can generally be identified based on size, thus avoiding the need for retrograde 
tracing experiments in many cases. We have also identified a population of giant lamina I projection 
cells that generally lack the NK1r and are characterised by the high density of excitatory and 
inhibitory synapses on their cell bodies and dendritic trees [35,43]. 
The mouse is increasingly used for investigations of spinal pain mechanisms, but little is known 
about the ALT in this species [14]. The present study therefore compared the organisation of the 
mouse spinoparabrachial projection to that of the rat. We aimed to determine the number of lamina 
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I spinoparabrachial neurons, the proportion that expressed NK1r, and whether, as in rat [3], these 
could be distinguished from other NK1r+ neurons based on soma size. We also tested whether giant 
lamina I cells in mouse belong to the spinoparabrachial tract. In preliminary studies we found that 
NK1r-immunoreactive cells were infrequent in lamina III-IV of the mouse, so we tested whether 
spinoparabrachial neurons were present in these laminae. We have shown that the somatostatin 
receptor sst2A is virtually restricted to GABA-immunoreactive (inhibitory) neurons in laminae I-II 
[37,54], however, Gamboa-Esteves et al. [18] detected sst2A on some lamina I projection neurons in 
rat. We therefore tested for sst2A expression by lamina I spinoparabrachial neurons and used 
anterograde tracing to assess the whether any of these cells were GABAergic. Finally, we looked 
for expression of neuropeptides, which has been reported for spinoparabrachial cells in other 
species [9,48].  
  
Methods 
Animals  
All experiments were approved by the Animal Welfare and Ethical Review Board of the 
University of Glasgow and were performed in accordance with the UK Animals (Scientific 
Procedures) Act 1986.  
Six adult C57Bl/6 mice of either sex (22-35g; Biological Services, University of Glasgow) were 
used in this study. They were anaesthetised with isoflurane and placed in a stereotaxic or spinal 
frame, after which anaesthetic was administered through a mask attached to the frame. In four 
cases, a burr hole was made through the skull, and a single injection of 200 or 300 nl of 1% cholera 
toxin B subunit (CTb) was targeted on the left LPb. In the other two cases, the lumbar vertebral 
column was exposed, and two injections of 150 nl of 1% CTb were made into the dorsal horn on 
one side of the spinal cord at a depth of 300 µm below the pial surface, through the intervertebral 
spaces rostral and caudal to the T13 vertebra. In all cases, injections were made through a glass 
micropipette, which was left in place for 5 minutes after completion of the injection, in order to 
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minimise leakage of tracer back up the track. All animals made an uneventful recovery from 
anaesthesia. After a 4 or 5 day survival period, they were re-anaesthetised with pentobarbitone (20 
mg i.p.) and perfused through the heart with a fixative that contained 4% freshly depolymerised 
formaldehyde.  
The brains and lumbar spinal cords were removed from all animals and post-fixed for at least 4 
hours, before being cut into sections with a vibrating blade microtome.  
 
General features of tissue processing and analysis 
From all 6 mice, the region of brain or spinal cord containing the injection site was cut into 
transverse sections (100 µm for brain, 60 µm for spinal cord), and injection sites were revealed by 
incubating the sections in goat antibody against CTb at 1:50,000-200,000 and performing an 
immunoperoxidase reaction, as described previously [1,47]. 
The L4 spinal cord segments from the LPb-injected animals were cut into 2 series of 60 µm thick 
transverse sections (each consisting of alternating sections), while the L5 segment and either L2 or 
L3 were cut into 60 µm horizontal sections. The part of the brainstem that included the LPb from 
the spinal-injected mice were cut into 4 series of 60 µm tranverse (coronal) sections. The sections 
were reacted for immunofluorescence staining, by incubating them for 3 days in mixtures of 
primary antibodies, and then in mixtures of species-specific secondary antibodies that were raised in 
donkey. The secondary antibodies were conjugated to Alexa 488, Alexa 647, Rhodamine Red, 
Pacific Blue or biotin (Jackson Immunoresearch) and were used at 1:500, apart from those 
conjugated to Pacific Blue (1:200) or Rhodamine Red (1:100). Biotinylated secondary antibodies 
were revealed with avidin-Pacific Blue (1:1000; Life Technologies). Following immunoreaction, 
the sections were mounted in anti-fade medium and stored at -20°C. All antibodies were diluted in 
PBS that contained 0.3% Triton-X100 and 5% normal donkey serum. The sources and dilutions of 
the primary antibodies are shown in Table 1. 
Sections reacted for immunofluorescence were scanned with a Zeiss LSM710 confocal 
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microscope equipped with Argon multi-line, 405 nm diode, 561 nm solid state and 633 nm HeNe 
lasers, and a spectral detection system. Confocal image stacks were acquired by scanning through a 
40× or  63× oil-immersion lens (NA 1.3 or 1.4, respectively) with the aperture set to 1 Airy unit. 
Scans through the spinal cord were scanned at a z-spacing of 1 or 2 µm, while those from the LPb 
were scanned at 0.5 µm z-spacing. 
 
Quantification of CTb-labelled lamina I neurons and expression of NK1 and sst2A receptors 
One series of transverse sections from the L4 segment of the mice that had received injections 
into the LPb was reacted with antibodies against CTb (raised in mouse), NK1r and sst2A. Seven 
sections were selected from each animal, before the CTb immunoreactivity was viewed. Two 
overlapping fields were scanned to include the whole superficial dorsal horn through the full 
thickness of the section, and these scans were analysed with Neurolucida for Confocal software 
(MBF Bioscience). The outline of the dorsal horn contralateral to the LPb injection was initially 
drawn, together with the ventral border of lamina I, which could be identified due to the plexus of 
NK1r-immunoreactive dendrites within the lamina. The channel representing CTb was visualised, 
and the locations of CTb-labelled cells were plotted onto these drawings. In order to avoid 
overcounting cells that were split by sectioning [20], we included cells if at least part of the nucleus 
(revealed as a filling defect in the CTb) was present in the first optical section in the z-series, and 
excluded them if part of the nucleus was present in the last optical section [1,41,47]. Because the 
analysis was performed on an alternate series of sections, it would not be possible for the same cell 
to be counted a second time on another section. The NK1r and sst2A channels were then viewed, and 
the presence or absence of each of these types of immunoreactivity was noted for each of the CTb-
labelled cells in the sample. In addition, a search was made for all lamina I cells that were 
immunoreactive for both NK1r and sst2A, and these were then examined to see whether they were 
CTb-labelled. 
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Analysis of soma sizes for NK1r neurons and identification of giant cells 
Horizontal sections from two segments (L5 and either L2 or L3) of each of the 4 LPb-injected 
mice were reacted with antibodies against CTb (mouse), NK1r, VGLUT2 and VGAT.  
The L5 sections were used to assess the soma sizes of NK1r-immunoreactive lamina I neurons 
[3]. The sections that contained numerous retrogradely labelled lamina I neurons on the side 
contralateral to the LPb injection were initially identified, and in this way either one or two sections 
were selected from each animal. These were then scanned through the 40× lens with the confocal 
microscope to generate overlapping z-stacks (2 µm z-separation) that included the whole of lamina I 
apart from its lateral part, which was not analysed due to the differing orientation of cells in this 
region [3]. The scans were analysed with Neurolucida for Confocal, such that only the channel 
representing NK1r-immunoreactivity was initially visible. The ventral border of lamina I could be 
readily identified, because the density of NK1r-immunoreactive cells is very low in lamina II. All 
NK1r+ cells with a soma that was entirely contained within the section were identified and drawn, 
and the cross-sectional area of the soma in the horizontal plane was measured from the drawings 
[3,43]. The channel representing CTb was then viewed, and the presence or absence of retrogradely 
transported CTb was noted for each of the NK1r+ cells. 
Sections from the two segments that had been cut into horizontal sections (L5 and either L2 or 
L3) were examined to look for giant lamina I cells, which can be recognised by the high density of 
VGLUT2- and VGAT-immunoreactive boutons that outline their cell bodies and dendrites [35,43]. 
These were initially identified by viewing the rhodamine channel (corresponding to VGLUT2), and 
then confirming the presence of numerous VGAT-immunoreactive boutons. Confocal z-stacks were 
then scanned to include the soma and proximal dendrites, and the presence or absence of CTb and 
NK1r was noted for each cell. 
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Projection neurons in lamina III-IV  
Retrogradely labelled neurons in lamina III and IV were examined in the second series of 
transverse sections of L4 from the 4 mice that received LPb injections. These sections were reacted 
with antibodies against CTb (mouse antibody), NK1r, calcitonin gene-related peptide (CGRP) and 
neuropeptide Y (NPY). This reaction was performed because the NK1r-immunoreactive 
anterolateral tract cells in laminae III and IV of the rat spinal cord are densely innervated by both 
peptidergic (CGRP+) primary afferents [32], and NPY-containing inhibitory interneurons [39,40]. 
The sections were initially viewed with fluorescence microscopy, and those that contained CTb-
labelled cells in laminae III-IV on the side contralateral to the LPb injection were identified. These 
cells were then scanned with the confocal microsope through the 40× lens to generate z-stacks (2 
µm z-separation) through the cell body and as much of the dendritic tree as was visible. In each 
case, the presence or absence of NK1r immunoreactivity was noted, and we determined whether the 
cell body and dendrites were associated with clusters of CGRP- and/or NPY-immunoreactive 
axons. 
 
Anterograde tracing 
One series of sections through the brainstem of the 2 mice that received spinal injections of CTb 
was reacted with antibodies against CTb (mouse antibody), VGAT and VGLUT2. A single section 
through the LPb that contained numerous CTb-labelled boutons was selected for analysis, and 
scanned with an oil-immersion lens to produce z-series of 25 or 30 optical sections at 0.5 µm z-
spacing. Overlapping scans were obtained from the entire region that contained CTb-labelled 
boutons in this section. The resulting z-stacks were viewed with Neurolucida for Confocal, and a 5 
µm × 5 µm grid was superimposed on the confocal images. A single optical section within the z-
stack was chosen before VGAT or VGLUT2 immunostaining were viewed, and CTb-labelled 
boutons were sampled by selecting the bouton nearest the bottom left hand corner of successive grid 
squares, starting near the dorsal- and lateral-most part of the LPb that contained these boutons and 
AC
EP
TE
D
 9 
progressing through the grid squares in a dorsal-ventral and then lateral-medial direction until the 
entire region containing CTb boutons had been covered [45]. The numbers of boutons analysed in 
the 2 mice were 100 and 208.  
Another series of sections was used to investigate neuropeptide expression by anterogradely 
labelled terminals in the LPb. The sections were reacted with antibodies against CTb (goat 
antibody), enkephalin, dynorphin B and SP. From each animal, two sections that contained 
numerous CTb-labelled boutons were selected and scanned as described above. Again, CTb+ 
boutons were selected before the other types of immunostaining were viewed, and the selected 
boutons were then examined to look for neuropeptide immunoreactivity. In order to compensate for 
any bias towards larger profiles in the selection process [20] we measured the z-axis lengths of each 
of the selected boutons by determining the number of z-sections on which it was present [21,45]. 
The numbers of boutons analysed in this part of the study were 280 and 391 for the 2 animals. 
   
Antibody characterisation  
Specificity of the CTb antibodies is demonstrated by the lack of staining in regions that did not 
contain injected or transported tracer. The NK1r antibody, raised against amino acids 393-407 of 
the rat NK1r, recognises a 46 kDa band in Western blots of rat brain extracts, and it has been shown 
that there is no staining with this antibody in mice in which the NK1r has been deleted [42]. The 
sst2A antibody was raised against the C terminal 15 amino acids of the mouse receptor, conjugated 
to keyhole limpet haemocyanin (KLH), and staining is abolished by pre-incubation of this peptide 
(manufacturer's specification). The CGRP antibody detects both α and β forms of the peptide. The 
NPY antibody was raised against synthetic NPY conjugated to bovine thyroglobulin, and is reported 
to show negligible cross-reactivity with a range of other peptides, including enkephalins, 
somatostatin, SP, angiotensin or vasoactive intestinal polypeptide (manufacturer's specification). 
The VGLUT2 antibody was raised against a synthetic peptide from rat VGLUT2, and we have 
shown that it stains identical structures to a well-characterised rabbit anti-VGLUT2 [51]. The 
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VGAT antibody was raised against amino acids 31-112 of the mouse protein, and recognises a 
single band of the appropriate size on Western blots [31]. The monoclonal SP antibody detects the 
C-terminal 5-8 amino acids of the peptide [10], and does not appear to recognise neurokinin B 
[29,38]. The dynorphin B antibody was raised against the full peptide, and does not cross-react with 
enkephalins [19]. Staining with this antibody is absent in the spinal cord of preprodynorphin 
knockout mice [23]. The monoclonal antibody against enkephalin recognises both Met- and Leu-
enkephalin, and shows significant cross-reactivity with C-terminal extended Met-enkephalin hexa- 
and heptapeptides, but not with either beta-endorphin or dynorphin (manufacturer's specification). 
 
Statistics 
The Mann-Whitney U-test was used to compare the soma areas of retrogradely-labelled and non-
labelled NK1r-immunoreactive lamina I neurons. Differences in the z-axis lengths of CTb-labelled 
boutons in the LPb that were tested for neuropeptide immunoreactivity were compared by using a t-
test. 
 
Results 
Injection sites 
Injection sites in the 6 mice are illustrated in Fig 1. In all 4 mice that received CTb injections 
into the brainstem, the immunoperoxidase reaction product filled the entire LPb, which extends 
from 1.16 to 1.88 mm caudal to the interaural plane [17] (Fig 1a,b). The injection sites also included 
most of the medial parabrachial area and Kolliker-Fuse nucleus and the caudalmost part of the PAG 
in all cases. There was variable spread into surrounding areas, including the cuneiform nucleus and 
cerebellum. The spinal cord injections were located in the L3-4 segments, and in both cases these 
filled most of laminae I-III of the ipsilateral dorsal horn (Fig 1c-e) at the levels of the injection. 
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Lamina I spinoparabrachial neurons: quantification and expression of NK1r and sst2A receptor 
Altogether, 276 CTb+ lamina I neurons (range 66-75, mean 69) were identified in the transverse 
sections of the L4 segments that were analysed from the 4 LPb-injected mice (7 sections per mouse; 
Table 2). This corresponds to a mean of 9.86 cells in each 60 µm thick section, and since we have 
estimated that the length of the L4 segment in the mouse is 1.45 mm [37], this suggests that there 
would have been an average of 238 spinoparabrachial lamina I cells on the contralateral side in the 
entire L4 segment in these animals. There are ~4500 lamina I neurons on each side in this segment 
in the mouse [37], and so we estimate that approximately 5.3% of these cells belong to the 
spinoparabrachial tract. 
As reported previously, immunoreactivity for both NK1r and sst2A receptor was present on cell 
bodies and dendrites in lamina I, and these were found on largely separate neuronal populations, 
although a few cells were immunoreactive for both receptors [37]. The great majority of the CTb-
labelled lamina I cells were NK1r-immunoreactive (Fig 2), with the proportion varying between 
79.4-93.9% among the 4 mice (mean 89.1%) (Table 2).  Sst2A-immunoreactivity was found on 26 of 
the CTb-labelled cells (between 4-10 per mouse), and this corresponded to between 5.3-15.1% 
(mean 9.5%) of the retrogradely labelled neurons (Table 2). All but 2 of the sst2A-immunoreactive 
CTb-labelled lamina I cells were also NK1r+. When the NK1r and sst2A channels were viewed, it 
was found that all of the lamina I cells that were immunoreactive for both receptors were 
retrogradely labelled with CTb. 
 
Soma sizes of NK1r+ lamina I neurons 
Between 187-279 (mean 245.8) NK1r-immunoreactive lamina I cells were identified and 
analysed in the horizontal sections through the contralateral sides of the L5 segments of the 4 LPb-
injected mice, and an example of the immunostaining for NK1r and CTb is shown in Fig 3a-c. The 
soma cross-sectional areas of the NK1r+ cells ranged from 52-1084 µm2, and showed a bimodal 
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distribution, with a major peak between 50-180 µm2, a smaller peak between 180-400 µm2, and a 
few cells with larger areas (Fig 3d). Between 17.3-25.2% (mean 20.2%) of the NK1r-
immunoreactive neurons were retrogradely labelled with CTb. There was a clear difference in the 
soma areas of the NK1r cells that were retrogradely labelled with CTb (range 116-1084 µm2, 
median 228 µm2) and those that were not (range 52-625 µm2, median 101 µm2), and this was highly 
significant (P <0.0001; Mann-Whitney U-test). The great majority (763/785, 97%) of NK1r cells 
with soma areas of less than 180 µm2 were not retrogradely labelled with CTb, whereas most 
(158/198, 80%) retrogradely labelled neurons had soma areas larger than 180 µm2. If a soma area of 
200 µm2 was taken as a cut-off value, then 140 (71%) of the retrogradely labelled cells would be 
included, but only 8 (1%) of the non-retrogradely labelled cells. In other words 95% of the NK1r 
cells with soma areas ≥200 µm2 were retrogradely labelled from the LPb in these experiments. 
 
Giant cells 
Altogether, 25 giant cells were identified in the horizontal sections from the 4 LPb-injected mice 
(3-8 cells per animal). In each case, the cell received numerous contacts from both VGLUT2- and 
VGAT-immunoreactive boutons. These boutons outlined the dendritic tree, and were also numerous 
on the cell body (Fig 4a,e). However, unlike the situation in the rat, in which virtually all of the 
giant cells can be retrogradely labelled from the LPb [43], only 8 of these cells (32%, between 0 and 
3 in each mouse) were labelled with CTb (Fig 4). As in the rat, we found that most of the giant cells 
(16/25, 64%) lacked the NK1r, although interestingly, all of the CTb-labelled cells (together with 
one of the cells that lacked CTb) were NK1r-immunoreactive (Fig 4). 
 
Spinoparabrachial neurons in laminae III-IV 
Retrogradely labelled neurons in lamina III-IV were counted in transverse sections of the L4 
segment from each of the 4 mice that had received an injection of CTb into the LPb. This analysis 
was carried out on sections that had been reacted with antibodies against CTb, NK1r, CGRP and 
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NPY, and between 11-13 sections were examined for each mouse (Table 3). Altogether, 18 CTb-
labelled cells (range 3-6, mean 4.5) were found in the contralateral dorsal horn in these laminae. 
Eight of these cells were NK1r-immunoreactive (Table 3), but these generally showed only weak or 
moderate immunoreactivity. Because of the small numbers found in each animal, we calculated the 
mean proportion that were NK1r-immunoreactive (8/18, 44%) for the entire sample. All 18 of these 
cells were associated with dense clusters of both CGRP-immunoreactive and NPY-immunoreactive 
boutons, which contacted their cell bodies, as well as their dendrites when these were visible (Fig. 
5). The total number of lamina III-IV spinoparabrachial cells in the contralateral part of the L4 
segment was estimated by dividing the rostrocaudal length of spinal cord examined (number of 
sections × 60 µm) into the total length of the segment (1.45 mm) [37] and multiplying this by the 
number of cells identified in the sections analysed. This gave a mean value of ~9 cells in the 
segment on the side contralateral to the LPb injection. 
During the course of this analysis, we also observed a few NK1r-immunoreactive cells in this 
region that were associated with CGRP and NPY axons, but were not CTb-labelled, as well as 
occasional clusters of CGRP and NPY axons that were not associated with cells that were either 
NK1r+ or CTb-labelled. 
 
Anterograde tracing 
Following injection of CTb into the lumbar dorsal horn, CTb-immunoreactive boutons were 
present in large numbers in the LPb (Fig 6a,b), in particular in the superior, central, dorsal and 
internal subnuclei [17]. However, little or no anterograde labelling was seen in the external or 
ventral parts of the LPb, or in the Köliker-Fuse nucleus or the medial parabrachial area. This 
distribution is generally similar to that reported in the corresponding regions of the rat LPb 
following injection of anterograde tracers into the lumbar spinal dorsal horn [16,46].  
The vast majority of the CTb-labelled boutons identified in the sections reacted for VGLUT2 
and VGAT (95% and 99% in the 2 mice, mean 97%) were VGLUT2-immunoreactive (Fig 6c-f), 
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while only 3% and 0.5% (mean 2%) were VGAT-immunoreactive. The remainder (2% and 1%, 
mean 1.5%) were not immunoreactive for either transporter. 
The results of peptide analysis are shown in Table 4, and an example of the immunostaining is 
shown in Fig 7. Although the majority of CTb-labelled boutons did not show any type of peptide 
immunoreactivity, 16% were SP-immunoreactive, with much smaller proportions (1-2%) showing 
dynorphin- or enkephalin-immunoreactivity. Very few of the CTb-labelled boutons showed more 
than one type of peptide immunoreactivity: altogether we found 3 CTb-labelled boutons that were 
immunoreactive for SP and dynorphin and one that was immunoreactive for SP and enkephalin. 
Discussion 
The main findings of this study are that: (1) spinoparabrachial cells account for ~5% of lamina I 
neurons in mouse lumbar enlargement; (2) ~90% of these cells are NK1r+, and they are generally 
larger than other NK1r+ neurons in this lamina; (3) only a minority of giant lamina I cells are 
labelled from the LPb; (4) many lamina III-IV spinoparabrachial neurons lack the NK1r, but as in 
the rat, they are innervated by both CGRP- and NPY-containing axons; and (5) spinoparabrachial 
axons originating from the superficial dorsal horn are nearly all glutamatergic, with some 
expressing SP. 
 
Identification of lamina I ALT neurons in the mouse 
By injecting different tracers into LPb and the other known major targets of lamina I cells, we 
have shown that in the rat, virtually all lamina I ALT neurons can be retrogradely labelled from the 
contralateral LPb [2,41,47]. We also demonstrated that among NK1r-immunoreactive neurons in 
this lamina, the great majority of the large cells could be identified as spinoparabrachial neurons, 
without the need for retrograde tracing experiments [3]. This raises three questions concerning the 
present study: (1) did we label all lamina I spinoparabrachial neurons? (2) can most lamina I 
projection neurons be retrogradely labelled from an injection centred on LPb? (3) can soma size be 
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used to distinguish between projection and non-projection cells among those that are NK1r-
immunoreactive? 
The LPb injection sites in our experiments included those regions that receive spinoparabrachial 
inputs [16,46], and numbers of retrogradely-labelled lamina I were highly consistent across the 4 
mice. Wang et al [56] reported that very large injections of Fluorogold  (500 nl of 4% Fluorogold) 
into the LPb in mice resulted in ~100 retrogradely labelled lamina I neurons per 500 µm of lumbar 
spinal cord, which is somewhat higher than our estimate of 9.86 cells per 60 µm (equivalent to 82 
cells/500 µm). However, Wang et al included cells both contralateral and ipsilateral to the LPb 
injection, which probably accounts for the slightly higher cell counts that they obtained. In fact, we 
have shown that if two different tracers are injected into the right and left LPb in the rat, most 
lamina I neurons labelled from the ipsilateral LPb are also labelled from the contralateral side, 
indicating that lamina I spinoparabrachial neurons project either contralaterally or bilaterally [47]. It 
is therefore likely that we labelled virtually all lamina I spinoparabrachial neurons in the present 
study. Since our aim was to label the maximum number of ALT neurons, we used relatively large 
injections of CTb that extended into adjacent regions including the caudal part of the PAG, which 
also receives collaterals from lamina I ALT neurons [50]. More restricted injections would be 
needed to assess the proportion of these cells that actually project to LPb. 
In order to test whether, as in the rat, most lamina I ALT cells are labelled from an injection into 
the LPb, it would be necessary to combine this with injections of a different tracer into all other 
known targets of these cells [2,41,47]. However, our finding that the vast majority of large NK1r+ 
lamina I neurons (soma area >200 µm2) were retrogradely labelled strongly suggests that this is also 
true for the mouse. The alternative explanation would be that there was a significant population of 
ALT projection neurons that did not send collaterals to LPb and that this consisted mainly of small 
NK1r-expressing neurons or cells that lacked the receptor. Another indirect piece of evidence in 
support of this hypothesis is that the LPb injections labelled ~5% of contralateral lamina I neurons, 
which is very similar to the proportion of neurons in this lamina that belong to the ALT in the rat 
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[47]. 
The great majority of lamina I spinoparabrachial cells (~90%) expressed the NK1r, and this 
proportion was even higher than that seen in the rat, in which 70-80% of spinoparabrachial neurons 
in this lamina are NK1r-immunoreactive [2,4,15,47,52]. As in the rat [3], there was a highly 
significant size difference between retrogradely labelled and non-labelled cells. For example, 95% 
of NK1r+ cells with soma areas >200 µm2 were CTb-labelled in the present series of experiments. 
This means that although immunostaining for the NK1r does not allow unequivocal identification of 
all lamina I projection neurons, it can be used to identify the larger NK1r-expressing 
spinoparabrachial cells with a reasonable degree of confidence, and without the need for retrograde 
tracing experiments. 
 
Differences between mouse and rat 
We found two major species differences in the organisation of projection neurons. Firstly the 
proportion of lamina I giant cells that could be labelled from the LPb, and secondly the lack of 
NK1r on many lamina III-IV spinoparabrachial neurons in the mouse. 
Giant lamina I cells in the rat form a sparse, but distinctive population, that differ from NK1r-
expressing projection neurons in their synaptic inputs and responses to noxious stimuli. They can 
readily be identified by the very high density of VGLUT2+ and VGAT+ boutons that almost 
completely outline their cell bodies and dendrites [35]. They also differ from the NK1r+ cells in that 
they receive very few contacts from peptidergic primary afferents and show significantly less 
expression of the transcription factor Fos after noxious thermal stimulation [35]. In the rat, we 
found that nearly all of these cells were retrogradely labelled from the LPb, and that they account 
for ~3% of spinoparabrachial cells in this lamina [35,43,50]. Examination of horizontal sections in 
the mouse revealed a similar population of large lamina I neurons that were coated with VGLUT2+ 
and VGAT+ boutons. However, only around one-third of these cells were retrogradely labelled. It is 
possible that the unlabelled giant cells were not projection neurons, but an alternative explanation is 
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that they project to other brain regions, and this will need to be assessed in future studies. 
The large NK1r-immunoreactive cells in lamina III-IV of the rat form another very distinctive 
and easily recognised population, which was identified in early studies of NK1r distribution 
[8,10,25-27,34]. These cells, which respond to noxious stimuli [36], were subsequently shown to be 
projection neurons, because >90% could be retrogradely labelled from the caudal ventrolateral 
medulla, and ~65% from LPb [52]. In the rat, they receive a highly selective synaptic input from 
two different populations of axons: peptidergic primary afferents, which contain both SP and CGRP 
[32], and NPY-containing axons. The latter are thought to be derived from local inhibitory 
interneurons, and account for one-third of the inhibitory synaptic input [39,40]. The present study 
shows that cells of this type are also present in the mouse and that they appear to have the same 
pattern of input from peptidergic primary afferents and NPY-containing interneurons. However, 
many of them lack the NK1r, or express it at low levels. Immunostaining for the receptor cannot 
therefore be used to reveal this population or to investigate their synaptic inputs, as has been done in 
the rat [6,32,33,39]. 
 
The neurochemical phenotype of lamina I projection neurons 
We previously reported that sst2A expression was restricted to GABAergic neurons in superficial 
dorsal horn of both rat and mouse [37,54]. The finding of sst2A on ~15% of lamina I neurons 
retrogradely labelled from the nucleus of the solitary tract in rat [18] therefore raised the possibility 
that some projection neurons in this lamina might be GABAergic. Consistent with the findings of 
Gamboa-Esteves et al. [18], we found that ~10% of lamina I spinoparabrachial neurons were sst2A+. 
However, nearly all of these cells also expressed the NK1r, which is thought to be restricted to 
excitatory (glutamatergic) neurons in this lamina [25]. We had previously identified a small 
population of lamina I neurons that expressed both sst2A and NK1r in the mouse [37], and the 
present results suggest that these are all projection neurons. Our finding that 97% of spino-
parabrachial axon terminals are VGLUT2-immunoreactive suggests that virtually all 
AC
CE
PT
ED
 18 
spinoparabrachial cells (including those with sst2A) are excitatory. Our failure to detect non-
GABAergic sst2A+ neurons [37] was probably because these constitute a very small population, 
corresponding to ~0.5% of all lamina I neurons, compared to 17% of neurons in this lamina that are 
sst2A-immunoreactive. 
Although Standaert et al. [48] detected both enkephalin and dynorphin in lamina I 
spinoparabrachial neurons, they had used colchicine to increase cytoplasmic peptide levels, and it is 
now known that this can cause abnormal peptide expression [13,44]. Our finding that only ~2% of 
spinoparabrachial terminals were immunoreactive for enkephalin or dynorphin suggests that few 
spinoparabrachial neurons normally express significant levels of either of these opioid peptides. 
However, in agreement with a previous study in the cat [9], we found that some spinoparabrachial 
terminals were SP-immunoreactive. Relatively little is known about SP-expressing neurons in the 
dorsal horn, as these contain levels of peptide that are not normally detected with immunocyto-
chemistry. However, in situ hybridisation has revealed cells with preprotachykinin 1 mRNA in 
laminae I-II [57], and non-primary SP-containing axons are seen both here and in the lateral spinal 
nucleus [12,51]. Since lamina I ALT neurons can generate local axon collaterals in both of these 
regions [49], at least some of the SP-containing non-primary glutamatergic axons [51] may be the 
collaterals of lamina I projection neurons.  
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FIGURE LEGENDS 
Fig. 1 Injection sites in the 6 mice used in this study. a Injection sites in the 4 experiments in which 
CTb was injected into the lateral parabrachial area. Each vertical column represents a single 
experiment. The darker shaded areas show the spread of tracer, while the pale shaded area is 
the superior cerebellar peduncle. Numbers to the left of the drawings correspond to the 
position of the section posterior to the interaural plane. Drawings are based on those of 
Franklin and Paxinos [16]. b a section through the brain from the mouse #4, corresponding 
to a level of ~1.5 mm caudal to the interaural plane. The CTb injection site appears as a dark 
area, and near the top of the image, the pipette track can be seen passing through the inferior 
colliculus. c, d drawings indicating the core of the injection site in the 2 mice that received 
intraspinal injections of CTb. e a section from the spinal cord of the mouse represented in c. 
Scale bars: b = 1 mm, c = 250 µm. IC, inferior colliculus; KF, Kölliker-Fuse nucleus; LPb, 
lateral parabrachial area; MPb, medial parabrachial area; PAG, periaqueductal grey matter. 
 
Fig. 2  Expression of NK1r and sst2A by retrogradely labelled spinoparabrachial neurons in lamina 
I. Confocal images showing a single optical section through the superficial dorsal horn in the 
L4 segment, contralateral to the LPb injection site. a CTb labelling (red) in 4 lamina I 
neurons identifies these as belonging to the spinoparabrachial tract. b, c immunostaining of 
the section for the NK1r (green) and sst2A (blue) shows that one of these cells (marked with 
an arrow) expresses both receptors, while the other 3 (asterisks) are only NK1r-
immunoreactive. Scale bar = 20 µm.   
 
Fig. 3 NK1r-immunoreactive projection neurons in lamina I. a-c: Confocal images from a 
horizontal section through the L5 segment of one of the mice that had received an injection 
of CTb into the LPb. The section has been scanned to reveal CTb (green) and NK1r 
(magenta). Six retrogradely labelled (CTb-positive) neurons are indicated with asterisks, and 
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each of these is NK1r-immunoreactive. In addition, several smaller NK1r-immunoreactive 
cells that are not retrogradely labelled (CTb-negative) are visible, and five of these are 
marked with arrowheads. Projection from 5 optical sections at 2 µm z-spacing. Scale bar = 
50 µm. d: Histograms showing the numbers of lamina I NK1r-immunoreactive cells with 
different soma areas. The top graph shows the results for all cells (All NK1r+), while the 
middle and lower graphs show those that were not labelled (NK1r+ non-retrograde), or 
retrogradely labelled (NK1r+ retrograde), respectively. The dashed line corresponds to a 
soma area of 180 µm2. Note that most of the non-retrogradely labelled neurons are smaller 
than this, while most retrogradely labelled cells are larger.  
 
Fig. 4 Giant lamina I neurons seen in horizontal sections. a-d: Confocal images showing a giant 
cell that was retrogradely labelled with CTb (green) and immunoreactive for the NK1r 
(grey). Note that many boutons containing VLGUT2 (red) or VGAT (blue) are associated 
with the cell body (*), and that these surround the dendrites (indicated by arrowheads). e-h: 
Another giant cell that was not retrogradely labelled, and lacked NK1r-immunoreactivity. 
Again, the soma (*) and dendrites (between arrowheads) are associated with numerous 
VGLUT2 and VGAT boutons. The two sets of images are projections of 5 (a-d) and 6 (e-h) 
optical sections at 1 µm z-spacing. Scale bar = 20 µm. 
 
Fig. 5 Innervation of a lamina III NK1r-negative projection neuron by CGRP- and NPY-containing 
axons. a: Confocal image showing part of a transverse section through a lamina III neuron 
that was retrogradely labelled with CTb (blue). b-d: The cell body is surrounded by axons 
that contain CGRP (red) or NPY (green). The inset in a shows the region through the cell 
body (*) stained for the NK1r, and this cell is not immunoreactive for the receptor. The 
images are projections of 4 optical sections at 2 µm z-spacing. Scale bar = 50 µm. 
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Fig. 6 VGLUT2 expression by anterogradely labelled spinoparabrachial axon terminals. a low-
magnification image through the LPb scanned to reveal CTb (red) and with dark-field 
optics. The LPb lies dorsal (d) and lateral (l) to the superior cerebellar peduncle (scp). b: 
The region shown in the box in a scanned at high magnification (15 optical sections at 0.5 
µm z-spacing) shows numerous CTb-labelled boutons. c-f: single optical section 
corresponding to the region shown in the box in b, scanned to reveal CTb, VGLUT2 (green) 
and VGAT (blue). Four CTb-labelled boutons are indicated with arrowheads. These are all 
VGLUT2-immunoreactive, and lack VGAT. Scale bars: a, 200 µm; b, 50 µm; c-f, 10 µm.  
 
Fig. 7 Expression of SP by anterogradely labelled spinoparabrachial terminals. a-b: A single 
optical section through the LPb reacted to reveal CTb (magenta) and substance P (SP, 
green). c: A merged image. Several CTb-labelled axonal boutons are visible, and some of 
these are SP-immunoreactive (two indicated with arrowheads). Scale bar = 10 µm. 
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Table 1 Primary antibodies used in this study 
 
Antibody Species Catalogue no Dilution Source 
CTb mouse ab35988 1:5,000 Abcam 
CTb goat 703 1:5,000 
1:50,000-200,000* 
List Biological 
NK1r rabbit S8305 1:2K Sigma Aldrich 
sst2A guinea pig SS870 1:2K Gramsch Laboratories 
CGRP guinea pig T-5027 1:10K Bachem 
NPY sheep AB1583 1:500 Millipore 
VGLUT2 guinea pig AB2251 1:5K Millipore 
VGAT goat  1:1K M Watanabe 
SP rat OBT06435 1:200 Oxford Biotech 
Dynorphin B rabbit  1:1K P Ciofi 
Enkephalin mouse MAB350 1:1K Millipore 
*rabbit anti-CTb was used at 1:50-200K for immunoperoxidase staining of injection sites 
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Table 2. NK1r and sst2A receptor immunoreactivity on CTb labelled lamina I neurons 
 
Mouse Total CTb+ cells % NK1r+/sst2A- % NK1r+/sst2A+ % NK1r-/sst2A+ 
1 68 75% 4.4% 1.5% 
2 66 80.3% 13.6% 1.5% 
3 67 80.6% 11.9% 0% 
4 75 85.3% 5.3% 0% 
Mean 69 80.3% 8.8% 0.7% 
 
The second column shows the total number of CTb-labelled cells that were identified in the 7 
transverse sections analysed from each of the 4 mice. Columns 3-5 show the proportion of these 
cells with different receptor expression patterns. 
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Table 3. NK1r receptor immunoreactivity on CTb labelled lamina III-IV neurons 
 
Mouse Total CTb+ 
cells 
Number with  
NK1r+ 
Number of sections 
analysed 
Estimated number 
in L4 segment 
1 6 2 11 13.18 
2 3 2 12 6.04 
3 5 1 13 9.29 
4 4 3 11 8.79 
Mean 4.5 2  9.33 
 
The estimate of total number of lamina III-IV spinoparabrachial in the L4 segment, shown in the 
5th column, was obtained by dividing the average length of the segment (1450 µm) by the length 
sampled (number of sections analysed × 60 µm) and multiplying this by the total number of CTb 
cells seen. 
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Table 4. Neuropeptide expression in anterogradely labelled spinoparabrachial boutons 
Mouse Number of CTb 
boutons 
% SP % dynorphin % enkephalin 
1 280 19.6% 2.5% 0.7% 
2 391 13.0% 1.5% 0.5% 
Mean  16.3% 2.0% 0.6% 
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